{"id":"NCT01178281","sponsor":"Celgene","briefTitle":"Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion-Dependence","officialTitle":"A Phase-3, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Compare Efficacy and Safety of Pomalidomide in Subjects With Myeloproliferative Neoplasm-Associated Myelofibrosis and Red Blood Cell-Transfusion-Dependence","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09-08","primaryCompletion":"2013-01-01","completion":"2018-05-15","firstPosted":"2010-08-10","resultsPosted":"2014-03-14","lastUpdate":"2019-07-17"},"enrollment":267,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Primary Myelofibrosis","MPN-associated Myelofibrosis"],"interventions":[{"type":"DRUG","name":"Pomalidomide 0.5 mg","otherNames":["CC-4047; Pomalyst; Imnovid"]},{"type":"DRUG","name":"Placebo","otherNames":[]},{"type":"DRUG","name":"Pomalidomide","otherNames":["CC-4047","Pomalyst","Imnovid"]}],"arms":[{"label":"Pomalidomide 0.5 mg","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"},{"label":"China Extension: Pomalidomide 0.5 mg","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to determine whether pomalidomide is safe and effective in reversing red blood cell (RBC)-transfusion-dependence in persons with myeloproliferative neoplasm (MPN)-associated myelofibrosis (global study) and in reversing anemia in Chinese with MPN-associated myelofibrosis and severe anemia not receiving RBC-transfusions (China extension study only)","primaryOutcome":{"measure":"Percentage of Participants Who Achieved RBC-Transfusion Independence","timeFrame":"168 days","effectByArm":[{"arm":"Pomalidomide 0.5 mg","deltaMin":17.3,"sd":null},{"arm":"Placebo","deltaMin":16.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"1.000"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":7,"exclusionCount":14},"locations":{"siteCount":87,"countries":["United States","Australia","Austria","Belgium","Canada","China","France","Germany","Italy","Japan","Netherlands","Poland","Russia","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["27773929","22081489"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":76,"n":167},"commonTop":["OEDEMA PERIPHERAL","FATIGUE","DIARRHOEA","PYREXIA","NAUSEA"]}}